Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

2 articles from 1 source · updated November 4, 2026, 17:02 UTC

Coverage

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa Seeking Alpha · November 4, 2026, 16:49 UTC
Moderna's Ebola Vaccine Candidate Selected for WHO-Recommended Phase 2/3 Trial Seeking Alpha · November 4, 2026, 16:49 UTC